Physician

Edward R Houser, MD

According to 2025 Medicare claims, Edward Houser, MD (NPI: 1649431024) practices urology in the Durham-Chapel Hill, NC market, with the plurality of this provider's patient population coming from Durham, NC. This provider's primary affiliated billing organization is TRIANGLE UROLOGY ASSOCIATES, P.A. (NPI: 1730181538; TIN: 561205950) and primary practice location at 27704-2125.

Houser's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 505 traditional Medicare patients, billed 4,515 HCPCS/CPT codes, and received $161,939 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 2,097 prescription claims across 510 beneficiaries totaling $1,091,243 in drug costs, led by Erleada (Apalutamide). DME data shows 16 claims. Open Payments data shows 104 records totaling $2,601. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $56,605 to $1,091,243. In contrast, DME billing represents a smaller volume and moved up and down with repeated peaks and valleys, starting at $300 and ending at $133.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	396	4,268	$127,224
2016	702	5,879	$183,973
2017	749	6,555	$196,001
2018	786	7,086	$199,613
2019	700	7,561	$199,013
2020	587	6,732	$162,061
2021	549	5,470	$145,678
2022	503	5,192	$186,321
2023	507	4,640	$147,076
2024	505	4,515	$161,939

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	221	1,087	$56,605
2016	346	1,412	$90,435
2017	470	2,234	$138,598
2018	513	2,455	$226,107
2019	513	2,367	$425,278
2020	452	2,206	$472,558
2021	461	2,071	$522,435
2022	454	2,022	$762,875
2023	450	1,977	$831,414
2024	510	2,097	$1,091,243

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	58	$13,970
2016	N/R	59	$22,677
2017	N/R	66	$19,297
2018	N/R	65	$21,081
2019	N/R	77	$22,976
2020	N/R	89	$31,044
2021	N/R	62	$16,703
2022	N/R	65	$22,458
2023	N/R	39	$14,777
2024	N/R	16	$4,455

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	98	124	$85
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	288	370	$62
99212	Established patient office or other outpatient visit with straightforward medical decision making, if using time, 10 minutes or more	99	112	$32
84153	Psa (prostate specific antigen) measurement, total	88	96	$18
81003	Automated urinalysis test	395	564	$2

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Erleada	Apalutamide	32	960	$455,043
Xtandi	Enzalutamide	21	750	$355,803
Myrbetriq	Mirabegron	128	5,616	$82,120
Orgovyx	Relugolix	27	810	$69,585
Gemtesa	Vibegron	43	2,570	$40,330

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
A4351	Intermittent urinary catheter; straight tip, with or without coating (teflon, silicone, silicone elastomer, or hydrophilic, etc.), each	N	N/R	16	$4,455

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	104	$2,601	Dendreon Pharmaceuticals LLC
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Edward R. Houser, MD?

Tedicare shows public-source Medicare data for Edward R. Houser, MD (NPI 1649431024), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Edward R. Houser, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Edward R. Houser, MD?

Edward R. Houser, MD is linked to TRIANGLE UROLOGY ASSOCIATES, P.A. (billing NPI 1730181538) in the available physician profile data.

Does Edward R. Houser, MD have Open Payments data?

Edward R. Houser, MD has 104 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.